We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Celanese (CE) Raises Selling Prices of Acetic Acid in China
Read MoreHide Full Article
Chemical and advanced materials maker Celanese Corporation (CE - Free Report) declared that it is raising the list and off-list selling prices of acetic acid by RMB 150/MT in China. The price hike will be effective immediately or as contracts permit.
Recently, Celanese also raised the list and off-list selling prices of acetic acid by €40/MT in Europe.
Celanese kept its earnings streak alive with a beat in third-quarter 2016. Moreover, its adjusted earnings of $1.67 per share increased 11.3% year over year. In the reported quarter, the company entered into a definitive agreement to fully acquire Forli, Italy-based SO.F.TER. Group, one of the largest independent thermoplastics compounders in the world. This acquisition will nearly double the number of Celanese global engineered materials platforms.
The company retained its expectations of 8–10% growth in adjusted earnings per share for 2016, factoring in the benefits of productivity actions and operational excellence as well as strength of commercial models.
Celanese’s strategic measures including productivity and efficiency improvement actions should lend support to its earnings in 2016. Further, the company is expected to gain from capacity expansion and growth initiatives in the emerging regions. Moreover, Celanese continues to generate strong cash flows and remains focused on returning value to its shareholders.
Koppers Holdings has an expected long-term growth of 10%. Chemours has an expected long-term growth of around 15.5%. Kronos Worldwide has an expected long-term growth of around 5%.
Confidential from Zacks
Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Celanese (CE) Raises Selling Prices of Acetic Acid in China
Chemical and advanced materials maker Celanese Corporation (CE - Free Report) declared that it is raising the list and off-list selling prices of acetic acid by RMB 150/MT in China. The price hike will be effective immediately or as contracts permit.
Recently, Celanese also raised the list and off-list selling prices of acetic acid by €40/MT in Europe.
CELANESE CP-A Price
CELANESE CP-A Price | CELANESE CP-A Quote
Celanese kept its earnings streak alive with a beat in third-quarter 2016. Moreover, its adjusted earnings of $1.67 per share increased 11.3% year over year. In the reported quarter, the company entered into a definitive agreement to fully acquire Forli, Italy-based SO.F.TER. Group, one of the largest independent thermoplastics compounders in the world. This acquisition will nearly double the number of Celanese global engineered materials platforms.
The company retained its expectations of 8–10% growth in adjusted earnings per share for 2016, factoring in the benefits of productivity actions and operational excellence as well as strength of commercial models.
Celanese’s strategic measures including productivity and efficiency improvement actions should lend support to its earnings in 2016. Further, the company is expected to gain from capacity expansion and growth initiatives in the emerging regions. Moreover, Celanese continues to generate strong cash flows and remains focused on returning value to its shareholders.
Celanese currently carries a Zacks Rank #2 (Buy).
Stocks to Consider
Some other well-placed companies in the chemical space include Koppers Holdings Inc. (KOP - Free Report) , The Chemours Company (CC - Free Report) and Kronos Worldwide, Inc. (KRO - Free Report) , all sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Koppers Holdings has an expected long-term growth of 10%.
Chemours has an expected long-term growth of around 15.5%.
Kronos Worldwide has an expected long-term growth of around 5%.
Confidential from Zacks
Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>